Mobile

GvHD prophylaxis with ATG-Fresenius S in allogenic Stem Cell Transplantation from matched unrelated donors: A randomised phase III multicenter trial comparing a standard GvHD prophylaxies with cyclosp...

Update Il y a 5 ans
Reference: EUCTR2004-000232-91

GvHD prophylaxis with ATG-Fresenius S in allogenic Stem Cell Transplantation from matched unrelated donors: A randomised phase III multicenter trial comparing a standard GvHD prophylaxies with cyclosporine A and Methotrexate with additional pretransplant ATG-Fresenius S

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Valutare l'efficacia di ATG-Fresenius S in aggiunta alla terapia standard (ciclosporina A/Metotressato) nel trattamento del fallimento precoce della terapia definito come il verificarsi della malattia del trapianto verso l'ospite di grado severo e acuta (grado III o IV) o di mortalita' precoce nei 100 giorni successivi al trapianto rispetto alla sola terapia standard.

Inclusion criteria

  • GvHD prophylaxis with ATG-Fresenius S in allogenic Stem Cell Transplantation from matched unrelated donors

Links